Balyasny Asset Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-541
| Closed | -$182K | – | 2822 |
|
|
2022
Q3 | $182K | Buy |
541
+238
| +79% | +$80.1K | ﹤0.01% | 1842 |
|
|
2022
Q2 | $100K | Buy |
+303
| New | +$100K | ﹤0.01% | 1834 |
|
|
2020
Q2 | – | Sell |
-479
| Closed | -$228K | – | 1383 |
|
|
2020
Q1 | $228K | Buy |
+479
| New | +$228K | ﹤0.01% | 908 |
|
|
2019
Q3 | – | Sell |
-338
| Closed | -$262K | – | 1501 |
|
|
2019
Q2 | $262K | Buy |
+338
| New | +$262K | ﹤0.01% | 1221 |
|
|
2019
Q1 | – | Sell |
-419
| Closed | -$196K | – | 1573 |
|
|
2018
Q4 | $196K | Sell |
419
-156
| -27% | -$73K | ﹤0.01% | 1204 |
|
|
2018
Q3 | $496K | Buy |
+575
| New | +$496K | ﹤0.01% | 1164 |
|
|
2017
Q4 | – | Sell |
-2,778
| Closed | -$1.37M | – | 2041 |
|
|
2017
Q3 | $1.37M | Sell |
2,778
-11,805
| -81% | -$5.82M | 0.01% | 900 |
|
|
2017
Q2 | $8.08M | Buy |
+14,583
| New | +$8.08M | 0.03% | 503 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 1556 |
|
|
2016
Q2 | – | Sell |
-290
| Closed | -$65K | – | 1276 |
|
|
2016
Q1 | $65K | Buy |
+290
| New | +$65K | ﹤0.01% | 1020 |
|